India, Oct. 26 -- Medifast, Inc. (MED), a metabolic health and wellness company, on Monday reported higher loss during the third quarter, impacted by restructuring charges and lower revenues. Further, the company issued fourth-quarter outlook expecting profit. For fiscal 2026, the company projects loss.
In the early morning trading on the NYSE, MED shares were gaining 5.51%, trading at $12.52.
In the third quarter, the company's net loss was $17.51 million, or $1.57 per share, compared to $2.26 million, or $0.21 per share, in the prior year quarter.
Adjusted net loss for the quarter was $2.1 million, or $0.19 per share.
Gross profit for the quarter decreased 19.5 percent to $50.04 million from $62.16 million in the third quarter of 2025...